- Home
- EVOK vs AQMS Comparison
EVOK vs AQMS Comparison
Compare EVOK & AQMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVOK
- AQMS
- Stock Information
- Founded
- EVOK 2007
- AQMS 2014
- Country
- EVOK United States
- AQMS United States
- Employees
- EVOK N/A
- AQMS N/A
- Industry
- EVOK Biotechnology: Pharmaceutical Preparations
- AQMS Metal Fabrications
- Sector
- EVOK Health Care
- AQMS Industrials
- Exchange
- EVOK Nasdaq
- AQMS Nasdaq
- Market Cap
- EVOK 5.4M
- AQMS 5.2M
- IPO Year
- EVOK 2013
- AQMS 2015
- Fundamental
- Price
- EVOK $5.12
- AQMS $3.89
- Analyst Decision
- EVOK
- AQMS Buy
- Analyst Count
- EVOK 0
- AQMS 1
- Target Price
- EVOK N/A
- AQMS $30.00
- AVG Volume (30 Days)
- EVOK 104.5K
- AQMS 65.5K
- Earning Date
- EVOK 08-14-2025
- AQMS 08-13-2025
- Dividend Yield
- EVOK N/A
- AQMS N/A
- EPS Growth
- EVOK N/A
- AQMS N/A
- EPS
- EVOK N/A
- AQMS N/A
- Revenue
- EVOK $12,794,859.00
- AQMS N/A
- Revenue This Year
- EVOK $57.82
- AQMS N/A
- Revenue Next Year
- EVOK $59.12
- AQMS $550.00
- P/E Ratio
- EVOK N/A
- AQMS N/A
- Revenue Growth
- EVOK 70.02
- AQMS N/A
- 52 Week Low
- EVOK $1.94
- AQMS $3.40
- 52 Week High
- EVOK $12.32
- AQMS $54.00
- Technical
- Relative Strength Index (RSI)
- EVOK 55.77
- AQMS 37.51
- Support Level
- EVOK $4.61
- AQMS $3.58
- Resistance Level
- EVOK $5.70
- AQMS $4.54
- Average True Range (ATR)
- EVOK 0.52
- AQMS 0.46
- MACD
- EVOK -0.03
- AQMS 0.07
- Stochastic Oscillator
- EVOK 71.01
- AQMS 26.63
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
About AQMS Aqua Metals Inc.
Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting, and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.